NO812039L - Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse - Google Patents

Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse

Info

Publication number
NO812039L
NO812039L NO812039A NO812039A NO812039L NO 812039 L NO812039 L NO 812039L NO 812039 A NO812039 A NO 812039A NO 812039 A NO812039 A NO 812039A NO 812039 L NO812039 L NO 812039L
Authority
NO
Norway
Prior art keywords
vincamine
preparations
acid
preparation
salt
Prior art date
Application number
NO812039A
Other languages
English (en)
Norwegian (no)
Inventor
Satish Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO812039L publication Critical patent/NO812039L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
NO812039A 1980-06-23 1981-06-16 Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse NO812039L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH480480 1980-06-23

Publications (1)

Publication Number Publication Date
NO812039L true NO812039L (no) 1981-12-28

Family

ID=4282830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812039A NO812039L (no) 1980-06-23 1981-06-16 Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse

Country Status (15)

Country Link
EP (1) EP0042818A1 (ko)
JP (1) JPS5762277A (ko)
KR (1) KR830005853A (ko)
AU (1) AU7201781A (ko)
DD (1) DD159737A5 (ko)
DK (1) DK274081A (ko)
ES (1) ES8203891A1 (ko)
FI (1) FI811934L (ko)
GB (1) GB2078758A (ko)
GR (1) GR75708B (ko)
IL (1) IL63148A0 (ko)
NO (1) NO812039L (ko)
NZ (1) NZ197485A (ko)
PT (1) PT73238B (ko)
ZA (1) ZA814194B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (ko) * 1955-08-08
FR2201898A1 (en) * 1973-05-30 1974-05-03 Sogeras Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders
FR2253507A1 (en) * 1973-12-11 1975-07-04 Houdet Antoine Vincamine administration using delayed release excipient - allowing prolonged action
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
PT66201B (fr) * 1976-02-23 1978-11-07 Corvi Mora E Procede et composition pour la therapeutique des maladies circulatoires cerebrales

Also Published As

Publication number Publication date
DK274081A (da) 1981-12-24
GR75708B (ko) 1984-08-02
ES503263A0 (es) 1982-04-01
JPS5762277A (en) 1982-04-15
KR830005853A (ko) 1983-09-14
NZ197485A (en) 1983-09-30
IL63148A0 (en) 1981-09-13
EP0042818A1 (de) 1981-12-30
ES8203891A1 (es) 1982-04-01
DD159737A5 (de) 1983-04-06
PT73238B (de) 1983-05-11
AU7201781A (en) 1982-01-07
ZA814194B (en) 1982-07-28
FI811934L (fi) 1981-12-24
PT73238A (de) 1981-07-01
GB2078758A (en) 1982-01-13

Similar Documents

Publication Publication Date Title
FI87525C (fi) Foerfarande foer framstaellning av en farmaceutisk hartskomposition med kontrollerad foerdroejd frigivning av dextrometorfanhydrobromid
NO792335L (no) Legemiddel-retardform med uopploeselige, poroese diffusjonsovertrekk
JPH0530804B2 (ko)
BRPI9915142B1 (pt) Novo material farmacêutico no formato de pérolas com liberação controlada, respectivo método de produção e formulação de múltiplas inidades compreendendo o mesmo
JP2003522127A (ja) オピオイド徐放性製剤
TW200540177A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
AU2002355624A1 (en) Crystalline composition containing escitalopram
CA2628031C (en) Once-daily administration of central nervous system drugs
US4861599A (en) Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
WO2021238978A1 (zh) 含硝羟喹啉前药的药物组合物及其制备方法和应用
US4369175A (en) Process for the manufacture of prolonged action vincamine preparations, the vincamine preparations so obtained, and medicaments containing them
NO140526B (no) Vernevisiranording for sikkerhetshjelm
CN116847831A (zh) 无定形固体分散系的药物组合物及其制备方法
ZA200109547B (en) Taste masked compositions.
IE891263L (en) Azelastine-containing medicaments with controlled release of¹the active substance
NO812039L (no) Fremgangsmaate til fremstilling av protrahert virkende vincamin-tilberedninger, saaledes dannede vincamin-tilberedninger og legemidler inneholdende disse
CZ20014379A3 (cs) Kompozice k maskování chuti a způsob její přípravy
JP6787928B2 (ja) リバスチグミン含有徐放出医薬組成物
US11602507B2 (en) Extended release oral composition of memantine or its salt and its process for the preparation
CN110917164B (zh) 一种苯磺酸米洛巴林缓释片及其制备方法
CN112972396A (zh) 一种非布司他控释组合物及其制备方法
KR100602235B1 (ko) 방출제어형 약제학적 조성물의 제조방법
CA2607272A1 (en) Formulations of mast cell stabilizing agents for delivery to the colon
CN109316455B (zh) 一种盐酸曲美他嗪缓释片
CN117883401A (zh) 一种伊来西胺固体分散体制剂及其制备方法